NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
31 hedge funds and large institutions have $2.94M invested in NKGen Biotech, Inc. Warrants in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
15% more funds holding
Funds holding: 27 → 31 (+4)
34% less capital invested
Capital invested by funds: $4.43M → $2.94M (-$1.49M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$83.2K |
| 2 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
+$66.6K |
| 3 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
+$46.1K |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$33.3K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$166 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$35K |
| 2 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$563 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $11K | – | – | – |
|
27
JP Morgan Chase
New York
| $11K | – | – | – |
|
|
VCIM
28
Velan Capital Investment Management
Alpharetta,
Georgia
| $11K | – | – | – |
|
|
GCIA
29
Gabelli & Co Investment Advisers
Rye,
New York
| $10K | – | – | – |
|
|
CCM
30
CAAS Capital Management
New York
| $6K | – | – | – |
|
31
Walleye Capital
New York
| $6K | – | – | – |
|
|
FLC
32
Fifth Lane Capital
Austin,
Texas
| $5K | – | – | – |
|
|
NRCM
33
Northern Right Capital Management
Darien,
Connecticut
| – | -$35K | -30,000 | Closed |
|
|
AA
34
Ancora Advisors
Cleveland,
Ohio
| – | +$166 | +200 | New |
|
NKGNW Hedge Fund Activity: Q1 2022 in Review
31 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q1 2022, worth a combined $2.94M — down 34% from $4.43M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NKGNW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $83.2K. The largest seller was Northern Right Capital Management, exiting entirely with an estimated $35K sold.
- 31 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q1 2022, up from 27 in Q4 2021.
- Funds reported $2.94M of NKGen Biotech, Inc. Warrants stock for Q1 2022, down 34% quarter-over-quarter.
- 5 funds opened new NKGen Biotech, Inc. Warrants positions in Q1 2022 and 1 closed out, a net change of +4 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $83.2K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q1 2022 was Northern Right Capital Management, an estimated $35K sold.
Based on aggregated 13F filings for Q1 2022.